Related references
Note: Only part of the references are listed.Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma
Maryam Fouladi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Susceptibility loci involved in cisplatin-induced cytotoxicity and apoptosis
Sunita J. Shukla et al.
PHARMACOGENETICS AND GENOMICS (2008)
Megalin genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin
L. Riedemann et al.
PHARMACOGENOMICS JOURNAL (2008)
Association between long-term neuro-toxicities in testicular cancer survivors and polymorphisms in glutathione-s-transferase-P1 and-M1, a retrospective cross sectional study
Jan Oldenburg et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2007)
Differential effects of glutathione S-transferase pi (GSTP1) haplotypes on cell proliferation and apoptosis
Sarah L. Holley et al.
CARCINOGENESIS (2007)
Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach
R. Stephanie Huang et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions
Kristin R. Knight et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Cisplatin-induced long-term hearing impairment is associated with specific glutathione S-transferase genotypes in testicular cancer survivors
Jan Oldenburg et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Identifying genetic variants that contribute to chemotherapy-induced cytotoxicity
Christine M. Hartford et al.
PHARMACOGENOMICS (2007)
Future opportunities in preventing cisplatin induced ototoxicity
J. H. van den Berg et al.
CANCER TREATMENT REVIEWS (2006)
Ototoxicity from high-dose use of platinum compounds in patients with neuroblastoma
Brian H. Kushner et al.
CANCER (2006)
Scale for chemotherapy-induced long-term neurotoxicity (SCIN):: Psychometrics, validation, and findings in a large sample of testicular cancer survivors
Jan Oldenburg et al.
QUALITY OF LIFE RESEARCH (2006)
Relationship between cisplatin administration and the development of ototoxicity
JM Rademaker-Lakhai et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Low incidence of ototoxicity with continuous infusion of cisplatin in the treatment of pediatric germ cell tumors
AA Gupta et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2006)
Hearing genes and cisplatin deafness: A pilot study
C Knoll et al.
LARYNGOSCOPE (2006)
Characteristics and risk factors of cisplatin-induced ototoxicity in testicular cancer patients detected by distorsion product otoacoustic emission
K. Biro et al.
ONCOLOGY (2006)
Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors - A children's Oncology Group study
N Marina et al.
CANCER (2005)
Screened and unscreened hearing threshold levels for the adult population: Results from the Nord-Trondelag Hearing Loss Study
B Engdahl et al.
INTERNATIONAL JOURNAL OF AUDIOLOGY (2005)
Glutathione S-transferase P1 genotype and prognosis in Hodgkin's lymphoma
S Hohaus et al.
CLINICAL CANCER RESEARCH (2005)
Cochlear structure and function after round window application of ototoxins
CA Bauer et al.
HEARING RESEARCH (2005)
Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss
J Wang et al.
CANCER RESEARCH (2004)
Heritability and linkage analysis of sensitivity to cisplatin-induced cytotoxicity
ME Dolan et al.
CANCER RESEARCH (2004)
Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose
Y Li et al.
EUROPEAN JOURNAL OF CANCER (2004)
Platinum compound-related ototoxicity in children - Long-term follow-up reveals continuous worsening of hearing loss
P Bertolini et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2004)
Curing metastatic cancer:: Lessons from testicular germ-cell tumours
JRW Masters et al.
NATURE REVIEWS CANCER (2003)
Quality of life in good prognosis patients with metastatic germ cell cancer:: A prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20)
SD Fosså et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Cisplatin ototoxicity involves organ of corti, stria vascularis and spiral ganglion: Modulation by alpha MSH and ORG 2766
FPT Hamers et al.
AUDIOLOGY AND NEURO-OTOLOGY (2003)
Allelic variants of the human glutathione S-transferase P1 gene confer differential cytoprotection against anticancer agents in Escherichia coli
TM Ishimoto et al.
PHARMACOGENETICS (2002)
Otoacoustic emissions, their origin in cochlear function, and use
DT Kemp
BRITISH MEDICAL BULLETIN (2002)
Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia
JM Allan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Glutathione S-transferase Mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1
SG Cho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Cisplatin-induced hearing loss: influence of the mode of drug administration in the guinea pig
A Ekborn et al.
HEARING RESEARCH (2000)
Glutathione S-transferase genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin
U Peters et al.
ANTI-CANCER DRUGS (2000)
Share Paper
